SCHEMBL7692273

SCHEMBL7692273

O=C(Nc1ccc(O)cc1)[C@H]1CCCN1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN3A Q9NY46 3/20 0.56
SCN9A Q15858 2/20 0.56
PSMB8 P28062 2/20 0.55
ALDH1A1 P00352 3/20 0.51
ULK1 O75385 1/20 0.51
TERT O14746 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
ESR2 Q92731 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SCN5A Q14524 1/20 0.47
DHODH Q02127 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29365790 1.00 SCN3A (0.56) SCN3ASCN9APSMB8ALDH1A1ULK1
SCHEMBL10281534 0.93 SCN3A (0.54) SCN3ASCN9APSMB8ALDH1A1ULK1
SCHEMBL13388756 0.89 SCN3A (0.64) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL13379539 0.86 SCN3A (0.58) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL7788050 0.86 SCN3A (0.62) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL24609551 0.86 SCN3A (0.55) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL17676974 0.86 SCN3A (0.55) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL1751199 0.86 SCN3A (0.55) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL873241 0.86 SCN3A (0.55) SCN3ASCN9APSMB8ULK1TERT
SCHEMBL1750392 0.86 SCN3A (0.58) SCN3ASCN9APSMB8ULK1TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263772-A1 COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION NEUMENTUM INC (US) 2023-08-24 US claimed
CN-113993846-A Compositions and methods for treating pain and/or inflammation 诺门图姆股份有限公司 2022-01-28 CN claimed
WO-2002070476-A1 PHENYLPYRROLES WITH A HERBICIDAL ACTIVITY ISAGRO RICERCA S.R.L. (IT) 2002-09-12 WO claimed
US-20230263772-A1 COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION NEUMENTUM INC (US) 2023-08-24 US disclosed
CN-113993846-A Compositions and methods for treating pain and/or inflammation 诺门图姆股份有限公司 2022-01-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263772-A1 COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION ADORA3, P2RX3, ADORA2A SCN3A 374/4885SCN9A 1975/4885PSMB8 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.